Clinical Trials Browser

Phase 1/2 × INDUSTRY × Cirrhosis, Familial, with Pulmonary Hypertension × Clear all

NCT06777316 2025-07-30

A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors

Phase 1/2 Recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma